Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Recombinant Anti-MUC1 (Clone Mc5)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone PAM4)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone HMFG1 (1.10.F3))
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone HMFG1 (1.10.F3))
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-MUC1 Reference Antibody (clivatuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-MUC1 Reference Antibody (gatipotuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-MUC1 Reference Antibody (AR20.5)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-MUC1 Reference Antibody (cantuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-MUC1 Reference Antibody (clivatuzumab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | MMAE |
Recombinant Anti-MUC1 (Clone Mc5)
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone PAM4)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone SM3)
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone HMFG2)
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- MUC1
Reactivities
- Human
Recombinant
- Recombinant Antibodies